United States Patent m Baak [il] 3,837,582 [45] Sept. 24, 1974 [54] BENEFICIATION OF NEW YORK STATE TALC [75] Inventor: Tryggve Baak, Princeton, N.J. [73] Assignee: Cyprus Mines Corporation, Trenton, N.J. [22] Filed: Dec. 27, 1972 [21] Appl.

tU^UILU <Jt*>5**7fc-

A RULES A ND REGULATIONS 11865 Title 20-- Employees' Benefits P a rt 405 of Chapter IH of Title 20 of CHAPTER ill-- SOCIAL SECURITY ADMIN ISTRATION, DEPARTMENT OF.

y !'

memo record from: Dr.

C^ 3 QUEBEC ASBESTOS M O TT O ASSOCIATION SU IT 413 O PXECIE V I LIOS M A M IE MONTEEAX n a , CANADA T E LE P H O N E B14) 0 7 8 -OBS te!

The Cosmetic, Toiletry and Fragrance Association, Inc. 1133 15th STREET, N.W., WASHINGTON, D.C, 20005 202/331-1770 TELEX 89-2873 TO: Talc Subcommittee FROM: Charles R.

H0AGLAN1 LONGO MODAU, DUNST a BOUNDS, LIP ATTORNEYS ai LAW 40 Paterson Street New Brunswick, NJ 08901 Tel: (732) 545-4717 Fax: (732) 545-4579 www.hoaglandlongo.com Katherine Blok Associate kblok@hoaglandlongo.com Food and Drug Administration Division of Freedom o f Information Office of the Executive Secretariat, OC 12420 Parklawn Drive ELEM-1029 Rockville, MD 20857 January 17, 2014 Re: Whittaker Clark & Daniels Our File No.: 5964698 - NJG To Whom It May Concern: This correspondence is intended to supplement our request for documents under the Freedom of Information Act, 5 U.S.C. 552, submitted electronically via FDA.gov.

MOUNT SINAI SCHOOL OF MEDICINE of The City University ofNew York P I P T H A V E N U E AND 100TH S T R E E T N E W YORK, N.Y. 10029 DepartmentofCommunityMedicine M a y 9, 1972 Mr.

/ \ .Scott Laboratories, Inc

AiianwriMMf JournalofCometto Seiaace 1,177-186 (1979) Normal use levels of respirable cosmetic talc: preliminary study R.

r -- - --- MEMO R E C O R D FRoti- i__ . i T0!

MEMBERSHIP LIST - CTFA TALC SUBCOMMITTEE G.

.* P h A R M A C E U T I C A L M A N U hA r\ / / / / '// September 11, 1975 Alexander M.

New York University Department of Chemistry 4 Washington Place, Room 410 New York, N.Y. 10003 Telephone: (212) 59S-3427 ATTACHMENT TO TABLE I* Memorandum to: Dr.